Treatment of Wounds Utilizing Light

Status Terminated

Clinical Trial Summary

The Qray device is emitting broad light energy that is intended for diabetic ulcer healing. The study is double blinded.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment

Related Conditions & MeSH terms

Diabetic Ulcer

Clinical Trial Details

NCT number	NCT00634868
Study type	Interventional
Source	QRay Ltd.
Contact
Status	Terminated
Phase	N/A
Start date	August 2008
Completion date	December 2010

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00804414` - Efficacy and Safety Study of Soluble Beta-1,3/1,6-glucan (SBG) Versus Placebo in Chronic Diabetic Foot Ulcers	Phase 3
Completed	`NCT00638872` - Polydeoxyribonucleotide -Placentex Mastelli(Pdrn) for the Treatment of Diabetic Ulcers	Phase 4
Completed	`NCT03070938` - PuraPly™ Antimicrobial Wound Matrix and Wound Management	N/A
Terminated	`NCT00871312` - Evaluation of Topical Wound Oxygen (two2) Therapy	N/A
Recruiting	`NCT06031714` - Fetal Cell Receptors Repertoire	N/A
Completed	`NCT03286452` - The RESPOND Registry
Not yet recruiting	`NCT03046628` - Evaluation of Lower Extremity Tissue Perfusion With Polarized Laser Light	N/A
Withdrawn	`NCT01353937` - Endogenous Progenitors Cell Therapy for Diabetic Foot Ulcers	Phase 1